CTCs predicted recurrence and death in patients with early-stage breast cancer

Combination therapy reduced HER2-positive breast cancers

Neoadjuvant therapy with lapatinib or trastuzumab for early breast cancer

Union for International Cancer Control: successes and the future

Computational modelling of signalling pathways

Chemoradiotherapy for bladder cancer

Cellular mechanisms of cancer cell dissemination and metastases formation

Roundtable discussion on the advances in myeloma and benefit for patients

Retreatment of ovarian cancer

Improving the care and support of people living with and beyond cancer

Personalising medicine in colorectal cancer

Cancer therapies that target DNA damage repair